Shareholders Unite Blog | Talkmarkets | Page 1
Retired Professor
Contributor's Links: Shareholders Unite

We at Shareholders Unite are retired university professors from Amsterdam writing with a focus on small-cap, macro, value, and momentum.

Our analysis can be read on both TalkMarkets and more

All Contributions

Latest Posts
1 to 9 of 9 Posts
E Orgenesis' Leveraged Approach To Lower The Cost Of Cell And Gene Therapies
Orgenesis is an innovative biotech company in the CGT (Cell & Gene Therapy) space.
E Medigus Is Facing Multiple Opportunities But Is Not Without Risk
While the company doesn't yet produce much in the way of revenues, it has stakes in multiple interesting opportunities and cash to last for quite a while. This is a high-risk, high-reward type of investment.
E Medigus, A High-Risk, High-Reward Micro-Camera Play
Medigus, is a company producing the highly innovative micro-camera and sensors ScoutCam, orders for which are taking off this year. The company which also produces the MUSE system for GERD treatment, a business which they intent to sell.
E Nxt-ID Gets A New Lease On Life
Nxt-ID has some promising businesses that are now about to be split with investors receiving shares of their finance business in a tax free distribution. What are the prospects?
Teladoc Health Looks Pretty Interesting
Teladoc is a big player in the rapidly rising, but still young, virtual care market. The company has multiple growth avenues in front of it but also some challenges which need to be overcome.
Boxlight Is Still Attractive
Despite a disappointing Q1, we think Boxlight is still an attractive buy as the bad quarter isn't likely to be the harbinger of a structural problem.
It's Still Not Too Late To Get On Board Of The BioLife Solutions Train
BLFS) is a stock to benefit from the early innings of regenerative medicine revolution with multiple avenues for growth ahead if it.BLFS
The Real Risk Of The Trade War
It is difficult to see the Chinese caving to the demands of the Trump government, which seem to involve a wholesale change of China's economic model.
Trump Versus The Dollar, Round 2
Trump has argued that the dollar is too strong, and he does have a point. A strong dollar is bad for US exports and corporate earnings, but there are also other ramifications. The problem is, there doesn't seem to be much he can do about it.
1 to 9 of 9 Posts